Deep Reactive Ion Etched Microneedle Array for in-vivo Cancer Monitoring via Cancer Exosome Isolation
Technology number: 2023-102
Using Oxygen Perfusion as a Biomarker for traumatic Brain Injury
Technology number: 2023-232
Automated Segmentation and Severity Analysis of Liver Parenchymal Disruption
Technology number: 2021-290
Iris Whole Slide Imaging -- Rapid Tile Buffering
Technology number: 2022-199
Tumor Response Assessment Platform
Technology number: 7208
Monitoring Response to Immunotherapy
Technology number: 2022-265
Spatial Relationship of Immune and Epithelial Cells to Diagnose, Prognosticate and Predict Treatment Efficacy
Technology number: 2021-063
Evaluation of Cell-Extracellular Vesicle Interaction using Novel Microfluidic Microsystem (CellExoChip)
TECHNOLOGY NUMBER: 2022-134
Risk Factors of Fibromuscular Dysplasia and Related Dysplasia-Associated Arterial Diseases
TECHNOLOGY NUMBER: 2022-233
Soluble Urokinase Plasminogen Activator Receptor (SuPAR) as a Therapeutic Target for Prevention and Treatment of Atherosclerosis
TECHNOLOGY NUMBER: 2021-428
Protein Biomarkers for Detection and Prediction of Cytokine Release Syndrome and Neurotoxicity during CAR T Cell Therapy
TECHNOLOGY NUMBER: 2021-417
Acetylcarnitine (C2) as a Biomarker for a Mortality Benefit from Supplemental L-carnitine in Patients with Septic Shock
TECHNOLOGY NUMBER: 2020-390
Digital Protein Biomarker Array for Multiplex Immunoassays
TECHNOLOGY NUMBER: 2019-323
Novel Blood Test to Predict Safe Foods for Infants and Toddlers with Food Protein-Induced Enterocolitis Syndrome (FPIES)
TECHNOLOGY NUMBER: 2019-143
Impeded Diffusion Fraction for Quantitative Imaging Diagnostic Assay
TECHNOLOGY NUMBER: 2021-130
Point-of-Care Blood Biomarker Analysis System
TECHNOLOGY NUMBER: 2019-118
Use of Soluble Urokinase Plasminogen Activator Receptor Levels in the Management of Patients with Cardiovascular Disease
TECHNOLOGY NUMBER: 2019-155
Methods to quantify metabolic activity in human tissues
TECHNOLOGY NUMBER: 2023-133
Methods to be Used in Conjunction with Biomarker Ratio Imaging Microscopy
TECHNOLOGY NUMBER: 2019-182
Spatial Patterns of Phosphofructokinase Isotypes within Ductal Carcinoma in Situ Lesions Accurately Predict Cancer Recurrences
TECHNOLOGY NUMBER: 2021-431
Retention Time Trajectory Matching for Peak Identification in Chromatographic Analysis
TECHNOLOGY NUMBER: 2021-241
Epithelial-Mesenchymal Transition-based Gene Expression Signature for Kidney Cancer
TECHNOLOGY NUMBER: 2022-045
12-HETE as a Diagnostic Tool for Early Detection of Cardiovascular and Thrombotic Risk
TECHNOLOGY NUMBER: 2021-106
Modified Tissue Factor with Increased Clotting Activity
TECHNOLOGY NUMBER: 2022-294
3D Printed Ankle Foot Orthosis with Modular Strut Configuration and Reconfigurable Stiffness
TECHNOLOGY NUMBER: 2019-154
Detection of CDK12 Alterations to Predict Prostate Cancer Therapeutic Sensitivity
TECHNOLOGY NUMBER: 2018-260
Understanding Lineage Plasticity Risk in Lethal Prostate Cancer
TECHNOLOGY NUMBER: 2022-131
Transepidermal Water Loss as an Anaphylaxis Monitoring Tool
TECHNOLOGY NUMBER: 2022-036
Intercellular Junction Proteins and Food Allergy
TECHNOLOGY NUMBER: 2020-239
Genetic Factors Influencing SCAD Risk
TECHNOLOGY NUMBER: 2020-231
A Non-Contact System and Method for Patient Motion Monitoring
TECHNOLOGY NUMBER: 2019-074
Microfluidic Flow Control using Direct-Current Peristaltic Pump
TECHNOLOGY NUMBER: 2020-236
Markers of L-Carnitine Drug Response in Patients with Sepsis
TECHNOLOGY NUMBER: 6190
Peptide Ligand Specific for CD44
TECHNOLOGY NUMBER: 2021-454
Tissue Factor Immunothromobotic Marker for COVID-19 and other Inflammatory Diseases
TECHNOLOGY NUMBER: 2021-089
Fast and Cost-Effective Isolation of Circulating Exosomes using Porous PDMS-Based Microsystem (PorousExoChip)
TECHNOLOGY NUMBER: 2022-135
Chiroptical Detection and Mutation Analysis of Cancer-Associated Extracellular Vesicles in Microfluidic Devices
TECHNOLOGY NUMBER: 2021-455
Polydiacetylene Liposome Microarray toward Facile Measurement of Platelet Activation in Whole Blood
TECHNOLOGY NUMBER: 2022-020
Method for Catalytic Glycosylation
TECHNOLOGY NUMBER: 2019-237
Abiraterone Analog for Prostate Cancer with Reduced Side Effects
TECHNOLOGY NUMBER: 2019-198
Peptide Specific for Fibroblast Growth Factor Receptor 2 for Detection and Therapy of Gastrointestinal Adenocarcinomas
TECHNOLOGY NUMBER: 7309
Peptide Ligand Specific for c-Met
TECHNOLOGY NUMBER: 2019-013
An Orientation-Independent Order Parameter Derived from Magnetic Resonance R1rho Dispersion in Ordered Tissue
TECHNOLOGY NUMBER: 2019-280